These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33901010)

  • 1. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
    Liu L; Li X; Shi Y; Chen H
    Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma.
    Zhou LL; Zhang M; Zhang YZ; Sun MF
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32894281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
    Xu C; He T; Li Z; Liu H; Ding B
    Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.
    Wang J; Zhang Y; You A; Li J; Gu J; Rao G; Ge X; Zhang K; Fu H; Liu X; Li J; Wang Q; Wu X; Cheng L; Zhu M; Wang D
    Cell Cycle; 2020 Nov; 19(21):2826-2835. PubMed ID: 33064966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
    Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
    Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase 59 pathway.
    Hu KQ; Ao XS
    Clinics (Sao Paulo); 2022; 77():100002. PubMed ID: 35113786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
    Wu D; Sun J; Wang H; Ma C
    Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
    Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
    Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF144A-AS1 promotes the development of glioma cells by targeting miR-665/HMGA1 axis.
    Tong X; Yang Z; Wang Q; Zhang D
    Neurosci Lett; 2021 Nov; 765():136259. PubMed ID: 34560189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686.
    Chai Y; Wu HT; Liang CD; You CY; Xie MX; Xiao SW
    Int J Nanomedicine; 2020; 15():8863-8872. PubMed ID: 33204092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA EGFR-AS1 is linked to migration, invasion and apoptosis in glioma cells by targeting miR-133b/RACK1.
    Dong ZQ; Guo ZY; Xie J
    Biomed Pharmacother; 2019 Oct; 118():109292. PubMed ID: 31545240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
    Wei N; Wei H; Zhang H
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
    Xiao S; Wang R; Wu X; Liu W; Ma S
    DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.